HK1255409A1 - 結合不動桿菌的抗體結合劑及其用途 - Google Patents
結合不動桿菌的抗體結合劑及其用途Info
- Publication number
- HK1255409A1 HK1255409A1 HK18114572.7A HK18114572A HK1255409A1 HK 1255409 A1 HK1255409 A1 HK 1255409A1 HK 18114572 A HK18114572 A HK 18114572A HK 1255409 A1 HK1255409 A1 HK 1255409A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- acinetobacter
- bind
- binding agents
- antibody binding
- antibody
- Prior art date
Links
- 241000589291 Acinetobacter Species 0.000 title 1
- 239000011230 binding agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1218—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Acinetobacter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/22—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Neisseriaceae (F), e.g. Acinetobacter
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562192029P | 2015-07-13 | 2015-07-13 | |
PCT/US2016/042124 WO2017011572A1 (en) | 2015-07-13 | 2016-07-13 | Antibody binding agents that bind acinetobacter and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1255409A1 true HK1255409A1 (zh) | 2019-08-16 |
Family
ID=57757609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18114572.7A HK1255409A1 (zh) | 2015-07-13 | 2018-11-15 | 結合不動桿菌的抗體結合劑及其用途 |
Country Status (5)
Country | Link |
---|---|
US (1) | US11306137B2 (zh) |
EP (1) | EP3322445A4 (zh) |
CN (1) | CN108472372B (zh) |
HK (1) | HK1255409A1 (zh) |
WO (1) | WO2017011572A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA202290208A1 (ru) * | 2019-07-02 | 2022-03-25 | Дзе Юнайтед Стейтс Оф Эмерика, Эз Репрезентед Бай Дзе Секретэри, Дипартмент Оф Хелт Энд Хьюман Сервисиз | МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА, КОТОРЫЕ СВЯЗЫВАЮТ EGFRvIII, И ИХ ПРИМЕНЕНИЕ |
CN116474081B (zh) * | 2023-06-19 | 2023-09-12 | 四川大学华西医院 | 鲍曼不动杆菌疫苗及制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103930131A (zh) * | 2011-05-13 | 2014-07-16 | 美国加州大学洛杉矶海滨分校医学中心的洛杉矶生物医学研究所 | 用于针对耐药性鲍氏不动杆菌的免疫的组合物和方法 |
US10160790B2 (en) * | 2011-09-14 | 2018-12-25 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | HYR1-derived compositions and methods of treatment using same |
EP2599496A1 (en) | 2011-11-30 | 2013-06-05 | Kenta Biotech AG | Novel targets of Acinetobacter baumannii |
CN102977208B (zh) * | 2012-12-12 | 2015-04-08 | 大连医科大学 | 鲍曼不动杆菌特异性卵黄免疫球蛋白的制备方法、应用及药物组合物、制剂和试剂盒 |
WO2016029079A2 (en) | 2014-08-21 | 2016-02-25 | Walter Reed Army Institute Of Research Department Of The Army | Monoclonal antibodies for treatment of microbial infections |
EP3777883A1 (en) | 2014-11-13 | 2021-02-17 | Evaxion Biotech ApS | Peptides derived from acinetobacter baumannii and their use in vaccination |
-
2016
- 2016-07-13 WO PCT/US2016/042124 patent/WO2017011572A1/en active Application Filing
- 2016-07-13 US US15/743,775 patent/US11306137B2/en active Active
- 2016-07-13 CN CN201680053003.9A patent/CN108472372B/zh active Active
- 2016-07-13 EP EP16825122.1A patent/EP3322445A4/en not_active Withdrawn
-
2018
- 2018-11-15 HK HK18114572.7A patent/HK1255409A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN108472372B (zh) | 2022-05-17 |
CN108472372A (zh) | 2018-08-31 |
WO2017011572A1 (en) | 2017-01-19 |
EP3322445A1 (en) | 2018-05-23 |
EP3322445A4 (en) | 2019-03-20 |
US20180215811A1 (en) | 2018-08-02 |
US11306137B2 (en) | 2022-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201803669B (en) | Antibodies specifically binding pd-1 and their uses | |
IL272643A (en) | Binders | |
ZA201808160B (en) | Bispecific binding proteins and uses thereof | |
IL275510A (en) | Specific antigen-binding molecules-ROR1 | |
HK1254029A1 (zh) | 人cd3結合抗體 | |
IL272524A (en) | CLEC9A binding factors and their use | |
IL254223A (en) | CD20 binding compounds and their uses | |
IL260846B (en) | Antigen binding proteins that bind pd-l1 | |
HK1250737A1 (zh) | 結合cd79的抗體分子 | |
ZA201701912B (en) | Antigen binding proteins that bind cxcr5 | |
ZA201804601B (en) | Psma binding antibody and uses thereof | |
ZA201901892B (en) | Antibodies that bind interleukin-2 and uses thereof | |
IL268288A (en) | Binders | |
IL266516B (en) | An antibody that specifically binds to cd66c and its use | |
HK1255409A1 (zh) | 結合不動桿菌的抗體結合劑及其用途 | |
IL267318A (en) | link test | |
GB201617935D0 (en) | Binding compound and uses thereof | |
GB201715149D0 (en) | IL-ß binding antibody | |
GB201713296D0 (en) | Binding agents | |
GB201713298D0 (en) | Binding agents | |
GB201701351D0 (en) | Binding agents |